Recent KNBIF News
- Kane Biotech Announces Grant of Stock Options • GlobeNewswire Inc. • 05/29/2026 09:05:00 PM
- Kane Biotech Announces First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/28/2026 09:05:00 PM
- Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering • GlobeNewswire Inc. • 05/26/2026 11:25:00 AM
- Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress • GlobeNewswire Inc. • 05/13/2026 11:25:00 AM
- Kane Biotech Announces New Private Placement Offering • GlobeNewswire Inc. • 05/07/2026 11:25:00 AM
- Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 04/23/2026 10:00:00 PM
- Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference • GlobeNewswire Inc. • 04/16/2026 11:25:00 AM
- Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms • GlobeNewswire Inc. • 03/17/2026 11:25:00 AM
- Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership • GlobeNewswire Inc. • 03/10/2026 11:25:00 AM
- Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal • GlobeNewswire Inc. • 02/20/2026 12:25:00 PM
- Kane Biotech Expands Commercial Activities in the United States • GlobeNewswire Inc. • 02/19/2026 12:25:00 PM
- Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser • GlobeNewswire Inc. • 02/17/2026 12:25:00 PM
- Kane Biotech Restarts Commercial Activities and Strengthens North American Management • GlobeNewswire Inc. • 02/12/2026 12:25:00 PM
- Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company • GlobeNewswire Inc. • 12/18/2025 12:25:00 PM
- Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting • GlobeNewswire Inc. • 12/17/2025 12:25:00 PM
- Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray • GlobeNewswire Inc. • 12/10/2025 12:25:00 PM
- Kane Biotech Announces Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/28/2025 12:25:00 PM
- Kane Biotech Announces New Private Placement Offering • GlobeNewswire Inc. • 11/27/2025 12:25:00 PM
- Kane Biotech Presents revyve® Data at Diabetic Foot and Southern Region Burn Conferences • GlobeNewswire Inc. • 11/04/2025 12:25:00 PM
- Kane Biotech Completes Enrollment in U.S. Case Series Studies of its revyve® Antimicrobial Wound Gel and Spray • GlobeNewswire Inc. • 09/10/2025 09:05:00 PM
